Windward Bio Group AG (WWB)
null: WWB ยท Real-Time Price ยท USD
24.01
+1.37 (6.05%)
Nov 19, 2026, 4:00 PM EST - Market closed
Windward Bio Group AG Earnings Call Transcripts
Fiscal Year 2026
-
WIN378 has advanced to phase III asthma testing, with phase II COPD dose-ranging ongoing and twice-yearly dosing as a key differentiator. WIN027 combines TSLP and IL-13 targeting, with global COPD and atopic dermatitis studies planned.